Stryker opens new R&D facility in India

Stryker (NYSE:SYK) this week introduced it opened a brand new analysis and construction facility in India.

Dubbed Stryker’s International Generation Middle (SGTC), the 150,000 sq. feet facility might be primarily based on the Global Tech Park in Gurgaon and can lend a hand boost up innovation in India.

“Innovation is in Stryker’s DNA. SGTC strengthens our talent to innovate and increase new merchandise and answers that lend a hand support and save lives world wide. We’re proud that Stryker undoubtedly affects greater than 100 million sufferers’ lives each and every 12 months and the call for for our choices is rising,” Stryker’s MedSurg and Neurotechnology Staff President Andy Pierce stated in a information unencumber.

Stryker established its first analysis and construction facility in India greater than 15 years in the past with the aim to reinforce R&D purposes in home and different rising markets. With greater than 1,000 staff at its first facility, the brand new SGTC furthers Stryker’s dedication to India.

“At the side of our shoppers, we’re pushed to make healthcare higher. We paintings to increase merchandise and answers that serve the original wishes of the marketplace and our shoppers around the globe. We’re desirous about the power of our present crew and the varied abilities our new heart will draw in, which is able to pressure innovation that advantages our shoppers and sufferers, no longer handiest within the area, however international. The brand new heart provides us room to develop and affect extra other people,” stated Ram Rangarajan, VP of R&D at Stryker’s SGTC.